{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:40Z","timestamp":1772119540952,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261201000026C"],"award-info":[{"award-number":["HHSN261201000026C"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA42014"],"award-info":[{"award-number":["P30 CA42014"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10552-019-01171-5","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T08:03:48Z","timestamp":1556352228000},"page":"581-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Population-based relative risks for specific family history constellations of breast cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Frederick S.","family":"Albright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh","family":"Neumayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saundra S.","family":"Buys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy B.","family":"Matsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Kaphingst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2602-3668","authenticated-orcid":false,"given":"Lisa A.","family":"Cannon-Albright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,27]]},"reference":[{"issue":"4","key":"1171_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/M13-1684","volume":"160","author":"HD Nelson","year":"2014","unstructured":"Nelson HD, Pappas M, Zakher B, Mitchell JP et al (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160(4):255\u2013266","journal-title":"Ann Intern Med"},{"issue":"1","key":"1171_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","volume":"15","author":"MB Daly","year":"2017","unstructured":"Daly MB, Pilarski R, Berry M, Buys SS, Farmer M et al (2017) NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2. 2017. J Natl Compr Canc Network 15(1):9\u201320","journal-title":"J Natl Compr Canc Network"},{"issue":"1","key":"1171_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.30428","volume":"140","author":"C Kraus","year":"2017","unstructured":"Kraus C, Hoyer J, Vasileiou G, Wunderle M et al (2017) Gene panel sequencing in familial breast\/ovarian cancer patients identifies multiple novel mutation also in genes other than BRCA1\/2. Int J Cancer 140(1):95\u2013102","journal-title":"Int J Cancer"},{"issue":"2","key":"1171_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75\u201389","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"1171_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"RM Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guideline from the European Society of Breast Imaging. Eur Radiol 18(7):1307\u20131318","journal-title":"Eur Radiol"},{"issue":"2","key":"1171_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-017-4247-z","volume":"164","author":"JA Cintolo-Gonzalez","year":"2017","unstructured":"Cintolo-Gonzalez JA, Braun D, Blackford AL et al (2017) Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. Breast Cancer Res Treat 164(2):263\u2013284","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1171_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00439-018-1944-6","volume":"137","author":"SA Narod","year":"2018","unstructured":"Narod SA (2018) Personalised medicine and population health: breast and ovarian cancer. Hum Genet 137(10):769\u2013778","journal-title":"Hum Genet"},{"key":"1171_CR8","first-page":"285","volume":"4","author":"M Skolnick","year":"1980","unstructured":"Skolnick M (1980) The Utah geneological database: a resourse for genetic epidemiology Banbury Report No 4. Cancer Incidence Defined Populations 4:285\u2013297","journal-title":"Cancer Incidence Defined Populations"},{"issue":"4","key":"1171_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000112368","volume":"65","author":"LA Cannon-Albright","year":"2008","unstructured":"Cannon-Albright LA (2008) Utah family-based analysis: past, present and future. Hum Hered 65(4):209\u2013220","journal-title":"Hum Hered"},{"key":"1171_CR10","volume-title":"Categorical data analysis","author":"A Agresti","year":"1990","unstructured":"Agresti A (1990) Categorical data analysis. Wiley, New York"},{"key":"1171_CR11","unstructured":"National Cancer Institute Breast Cancer Risk Assessment Tool\u00a0\n                    https:\/\/bcrisktool.cancer.gov\/Viewed\n                    \n                   on November 7, 2018"},{"key":"1171_CR12","unstructured":"U.T. Southwestern Medical Center at Dallas and the BayesMendel Group. CancerGene with BRCApro, MMRpro, PancPro, and MelaPro. VersionCaGene6. \n                    http:\/\/www4.utsouthwestern.edu\/breasthealth\/cagene\/\n                    \n                   Viewed on November 7, 2018"},{"key":"1171_CR13","unstructured":"IBIS Breast Cancer Risk Evaluation Tool v8.\u00a0\n                    http:\/\/www.ems-trials.org\/riskevaluator\/\n                    \n                  . Viewed on November 7, 2018"},{"key":"1171_CR14","doi-asserted-by":"publisher","unstructured":"Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC, The Consortium of Investigators of Modifiers of BRCA1\/21 and The Breast Cancer Association Consortium, BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, British Journal of Cancer, online publication 17 December 2013. \n                    https:\/\/doi.org\/10.1038\/bjc.2013.730","DOI":"10.1038\/bjc.2013.730"},{"issue":"8","key":"1171_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","volume":"32","author":"KH Lu","year":"2014","unstructured":"Lu KH, Wood ME, Daniels M, Burke C, Ford J et al (2014) American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol 32(8):833\u2013840","journal-title":"J Clin Oncol"},{"issue":"10","key":"1171_CR16","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djq088","volume":"102","author":"E Amir","year":"2010","unstructured":"Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102(10):680\u2013691. \n                    https:\/\/doi.org\/10.1093\/jnci\/djq088","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"1171_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/jnci\/djr114","volume":"103","author":"PL Mai","year":"2011","unstructured":"Mai PL, Garceau AO et al (2011) Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst 103(10):788\u2013797","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1171_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0749-3797(02)00593-7","volume":"24","author":"A Ziogas","year":"2003","unstructured":"Ziogas A, Anton C (2003) Validation of family history data in cancer family registries. Am J Prev Med 24(4):190\u2013198","journal-title":"Am J Prev Med"},{"issue":"4\u20135","key":"1171_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000273689","volume":"14","author":"C Wang","year":"2011","unstructured":"Wang C, Gallo RE, Fleisher L, Miller SM (2011) Literacy assessment of family health history tools for public health prevention. Public Health Genomics 14(4\u20135):222\u2013237. \n                    https:\/\/doi.org\/10.1159\/000273689","journal-title":"Public Health Genomics"},{"issue":"5","key":"1171_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3949\/ccjm.79a.11065","volume":"79","author":"M Doerr","year":"2012","unstructured":"Doerr M, Teng K (2012) Family history: still relevant in the genomics era. Cleve Clin J Med 79(5):331\u2013336","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"1171_CR21","first-page":"231","volume":"16","author":"L Aiyar","year":"2014","unstructured":"Aiyar L, Shuman C, Hayeems R, Dupuis A, Pu S, Wodak S, Chitayat D, Velsher L, Davies J (2014) Risk estimates for complex disorders: comparing personal genome testing and family history. Gen in Med 16(3):231\u2013237","journal-title":"Gen in Med"},{"key":"1171_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/ejhg.2011.224","volume":"20","author":"B Heald","year":"2012","unstructured":"Heald B, Edelman E, Eng C (2012) Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. EJHG 20:547\u2013551","journal-title":"EJHG"},{"issue":"1","key":"1171_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/gepi.20664","volume":"36","author":"CS Bloss","year":"2012","unstructured":"Bloss CS, Topol EJ, Schork NJ (2012) Association of direct-to-consumer genome-wide disease risk estimates and self-reported disease. Genet Epidemiol 36(1):66\u201370","journal-title":"Genet Epidemiol"},{"key":"1171_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","volume":"165","author":"HR Brewer","year":"2017","unstructured":"Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ (2017) Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat 165:193\u2013200","journal-title":"Breast Cancer Res Treat"},{"issue":"9291","key":"1171_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389\u20131399","journal-title":"Lancet"},{"issue":"3","key":"1171_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<386::AID-IJC13>3.0.CO;2-6","volume":"77","author":"K Hemminiki","year":"1998","unstructured":"Hemminiki K, Vaittinen P (1998) Familial breast cancer in the family-cancer database. Int J Cancer 77(3):386\u2013391","journal-title":"Int J Cancer"},{"issue":"4","key":"1171_CR27","first-page":"836","volume":"36","author":"T McLellan","year":"1984","unstructured":"McLellan T, Jorde LB, Skolnick MH (1984) Genetic distances between the utah mormons and related populations. Am J Hum Genet 36(4):836\u2013857","journal-title":"Am J Hum Genet"},{"key":"1171_CR28","unstructured":"Public Health Indicator Based Information System (IBIS). Complete health indicator report of breast cancer incidence. \n                    https:\/\/ibis.health.utah.gov\/indicator\/complete_profile\/BreCAInc.html\n                    \n                  . Accessed 7 December 2014"},{"key":"1171_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13059-016-1107-9","volume":"17","author":"N Katanis","year":"2016","unstructured":"Katanis N (2016) The continuum of causality in human genetic disorders. Genome Biol 17:233","journal-title":"Genome Biol"},{"issue":"3","key":"1171_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1053\/j.gastro.2009.11.044","volume":"138","author":"DP Taylor","year":"2010","unstructured":"Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA (2010) Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 138(3):877\u2013885. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2009.11.044","journal-title":"Gastroenterology"},{"issue":"4","key":"1171_CR31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/pros.22925","volume":"75","author":"FS Albright","year":"2015","unstructured":"Albright FS, Stephenson RA, Agarwal N, Teerlink CC, Lowrance WT, Farnham JM, Cannon-Albright LA (2015) Prostate cancer risk prediction based on complete prostate cancer family history. Prostate 75(4):390\u2013398. \n                    https:\/\/doi.org\/10.1002\/pros.22925","journal-title":"Prostate"},{"key":"1171_CR32","doi-asserted-by":"publisher","unstructured":"Albright FS, Stephenson RA, Agarwal N, Cannon-Albright LA (2016) Relative Risks for lethal prostate cancer based on complete family history of prostate cancer death. Prostate. \n                    https:\/\/doi.org\/10.1002\/pros.23247\n                    \n                  . (Epub ahead of print)","DOI":"10.1002\/pros.23247"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-01171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-019-01171-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-019-01171-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T16:05:56Z","timestamp":1589645156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-019-01171-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,27]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s10552-019-01171-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/136051","asserted-by":"object"}]},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,27]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets generated and analyzed during the current study are not publicly available. The Utah Resource for Genetic and Epidemiologic Research (RGE) and Institutional Review Boards (IRB) administer access to the UPDB resource (\n                      \n                      ) through a review process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Approval for this research was received from the University of Utah School of Medicine Institutional Review Board and from the Resource for Genetic and Epidemiologic Research which oversees the UPDB.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}